Last updated: July 19, 2023
Sponsor: Assistance Publique - Hôpitaux de Paris
Overall Status: Active - Recruiting
Phase
1
Condition
Covid-19
Treatment
Lymph node aspiration / Blood sampling
Clinical Study ID
NCT05951920
APHP230684
2023-A01335-40
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Male or female aged 18 years and over included in COVIBOOST 2
Exclusion
Exclusion Criteria:
- Hypersensitivity to lidocaine, to anaesthetics of the amide type or to any of theexcipients
- Patient with recurrent porphyrias
Study Design
Total Participants: 12
Treatment Group(s): 1
Primary Treatment: Lymph node aspiration / Blood sampling
Phase: 1
Study Start date:
July 05, 2023
Estimated Completion Date:
September 30, 2023
Study Description
Connect with a study center
GH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur
Paris, 75679
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.